中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2014年
4期
151-152
,共2页
辛伐他汀%阿托伐他汀%冠心病%血脂水平
辛伐他汀%阿託伐他汀%冠心病%血脂水平
신벌타정%아탁벌타정%관심병%혈지수평
simvastatin%atorvastatin%coronary heart disease%serum lipid levels
目的：评价辛伐他汀和阿托伐他汀对冠心病患者的降血脂作用。方法选取2013年1月～2014年1月于山东省聊城市第三人民医院收治的150例冠心病患者，采用随机法分为A、B 2组，每组75例。A组患者给予辛伐他汀治疗，B组患者给予阿托伐他汀治疗。比较2组患者治疗前后血脂变化情况。结果治疗后，A、B 2组患者临床症状得到缓解；TC、LDL-C指标均明显下降，与治疗前相比差异有统计学意义（P＜0.05）；但A、B 2组组间比较差异无统计学意义。结论辛伐他汀和阿托伐他汀均能有效改善患者血脂情况。
目的：評價辛伐他汀和阿託伐他汀對冠心病患者的降血脂作用。方法選取2013年1月～2014年1月于山東省聊城市第三人民醫院收治的150例冠心病患者，採用隨機法分為A、B 2組，每組75例。A組患者給予辛伐他汀治療，B組患者給予阿託伐他汀治療。比較2組患者治療前後血脂變化情況。結果治療後，A、B 2組患者臨床癥狀得到緩解；TC、LDL-C指標均明顯下降，與治療前相比差異有統計學意義（P＜0.05）；但A、B 2組組間比較差異無統計學意義。結論辛伐他汀和阿託伐他汀均能有效改善患者血脂情況。
목적：평개신벌타정화아탁벌타정대관심병환자적강혈지작용。방법선취2013년1월～2014년1월우산동성료성시제삼인민의원수치적150례관심병환자，채용수궤법분위A、B 2조，매조75례。A조환자급여신벌타정치료，B조환자급여아탁벌타정치료。비교2조환자치료전후혈지변화정황。결과치료후，A、B 2조환자림상증상득도완해；TC、LDL-C지표균명현하강，여치료전상비차이유통계학의의（P＜0.05）；단A、B 2조조간비교차이무통계학의의。결론신벌타정화아탁벌타정균능유효개선환자혈지정황。
Objective To evaluete the effect of atorvastatin on reducing blood lipid in patients with coronary heart disease.Methods 150 cases of coronary heart disease patients collected in Liaocheng Third People’s Hospital of Shandong province from January 2013 to January 2014 were randomly divided into A,B two groups,each had is cases.Group A were treated with simvastatin,and group B were treated with atorvastatin.Blood lipid changes in two groups before and after treatment were compared. Results Compared with before treatment,the clinical sypotoms after treatment in two groups were allivate and TC,LDL-C indexes were significantly decreased (P <0.05 ).But there was no statistical significance between A and B groups. Conclusion Simvastatin and atorvastatin can effectively improve the blood lipid status in patients with coronary heart disease.
